NVZMF:OTCMKTS
Novozymes A/S
$65.24
arrow_downward
-2.44%(-1.63) 1D
Sep 10, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVZMF...
Open
$65.24
High
$65.24
Low
$65.24
Mkt. cap
179.46B
Avg. vol.
355.00
Volume
110.00
52-wk high
$72.98
52-wk low
$52.10
Beta
0.87
Shares outstanding
414.56M
No. of employees
11K
Open
$65.24
High
$65.24
Low
$65.24
Mkt. cap
179.46B
Avg. vol.
355.00
Volume
110.00
52-wk high
$72.98
52-wk low
$52.10
Beta
0.87
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
lifesciencenordic.com
·
14 hours ago
Novonesis to invest €600 million in India factory
AD HOC NEWS
·
3 days ago
Novonesis stock steadies after latest earnings update
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S